Abstract
The sensitivity of breast cancer cells to epirubicin (EPI) is closely related to the efficacy of the drug and the prognosis of patients. A growing body of research has suggested that autophagy is involved in the treatment of a variety of cancers, including breast cancer, and modifies the sensitivity of anticancer drugs. However, the mechanism by which autophagy participates in cancer therapy and modulates drug sensitivity has not been fully elucidated. In this study, we showed that the expression of Autophagy/Beclin 1 regulator 1 (Ambra1), a key protein of autophagy, was negatively correlated with EPI sensitivity in breast cancer cells. In addition, it altered the sensitivity of breast cancer cells to EPI by regulating EPI-induced autophagy. As a potential mechanism, we demonstrated that autophagy-related protein 12 (ATG12) was a downstream protein that Ambra1-regulated EPI-induced autophagy. Therefore, Ambra1 plays an important role in regulating the sensitivity of breast cancer cells to EPI. And the regulatory effect of Ambra1 on EPI sensitivity is achieved through the regulation of autophagy by targeting ATG12. Overall, we propose a novel mechanism by which autophagy modulates the sensitivity of breast cancer cells to EPI. A...Continue Reading
References
Dec 22, 1999·Nature·X H LiangB Levine
Nov 4, 2000·The EMBO Journal·Y KabeyaT Yoshimori
Sep 5, 2002·Biochemical and Biophysical Research Communications·Isei TanidaEiki Kominami
May 8, 2004·Science·Li YuMichael J Lenardo
Sep 9, 2005·Nature Reviews. Cancer·Yasuko KondoSeiji Kondo
Nov 16, 2005·The Journal of Cell Biology·Geir BjørkøyTerje Johansen
Jun 21, 2007·The Journal of Biological Chemistry·Serhiy PankivTerje Johansen
Jun 26, 2007·Nature·Gian Maria FimiaFrancesco Cecconi
Aug 23, 2007·Nature Reviews. Molecular Cell Biology·Daniel J Klionsky
Aug 16, 2008·EMBO Reports·Jiefei Geng, Daniel J Klionsky
Jun 8, 2011·Autophagy·Wei-Liang SunHong Zheng
Mar 24, 2012·Cell Death and Differentiation·V PagliariniM Piacentini
Jun 1, 2012·Autophagy·Bin TangXu-Hu Mao
Oct 17, 2012·Oncogene·G M FimiaM Piacentini
Dec 4, 2012·Nature Structural & Molecular Biology·Chinatsu OtomoTakanori Otomo
Jul 3, 2013·Seminars in Cancer Biology·Séverine LorinPatrice Codogno
Oct 12, 2013·Cell Death & Disease·X SuiH Pan
Mar 4, 2014·PloS One·Wen GuSongbing He
Sep 5, 2014·Cell Death & Disease·M YazdankhahF Cecconi
Mar 10, 2015·Annual Review of Biophysics·Nobuo N Noda, Fuyuhiko Inagaki
Jun 3, 2015·Journal of Cell Science·Valentina CianfanelliFrancesco Cecconi
Jan 23, 2016·Autophagy·Daniel J KlionskySusu M Zughaier
Apr 22, 2016·Clinical and Experimental Pharmacology & Physiology·Shu-Ting PanShu-Feng Zhou
Jan 1, 2015·Molecular & Cellular Oncology·Valentina CianfanelliFrancesco Cecconi
Jun 28, 2016·Oncology Letters·Wei-Liang Sun
Aug 26, 2016·Cancer Science·Wei GuoHong Zheng
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 31, 2017·Microbial Cell·Zhangyuan YinDaniel J Klionsky
Aug 5, 2017·Scientific Reports·Christian GarbarArmand Bensussan
Aug 29, 2017·International Journal of Molecular Sciences·Saori R Yoshii, Noboru Mizushima
Citations
Jan 29, 2020·Journal of Cellular and Molecular Medicine·Jun MaMingyi Shang
Jul 11, 2020·Aging·Baoai HanRuifang Niu
Sep 8, 2020·Journal of Zhejiang University. Science. B·Nan WenZheng-Gui Du
Nov 14, 2019·Cancers·Cally J Ho, Sharon M Gorski
Feb 14, 2020·International Journal of Molecular Sciences·Pauline J Beckmann, David A Largaespada
Nov 13, 2020·Frontiers in Pharmacology·Xiao-Long YuanPeng Zhang
May 22, 2019·Seminars in Cell & Developmental Biology·Tânia CapelôaPierre Sonveaux
May 4, 2020·The American Journal of the Medical Sciences·Yanli NieFuxiang Zhou
Feb 20, 2021·PeerJ·Mengya WangLiping Sun
Apr 29, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Aurelian Udristioiu, Delia Nica-Badea
Oct 13, 2021·Bioengineered·Guangzhen WuFeng Chen
Dec 4, 2021·Journal of Cell Science·Yuxia LinPing Zhang